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Abstract
Background: Spontaneous premature ovarian failure presents most commonly with secondary
amenorrhea. Young women with the disorder are infertile and experience the symptoms and
sequelae of estrogen deficiency. The mechanisms that give rise to spontaneous premature ovarian
failure are largely unknown, but many reports suggest a genetic mechanism in some cases. The small
family size associated with infertility makes genetic linkage analysis studies extremely difficult.
Another approach that has proven successful has been to examine candidate genes based on known
genetic phenotypes in other species. Studies in mice have demonstrated that c-kit, a
transmembrane tyrosine kinase receptor, plays a critical role in gametogenesis. Here we test the
hypothesis that human KIT mutations might be a cause of spontaneous premature ovarian failure.
Methods and Results: We examined 42 women with spontaneous premature ovarian failure and
found partial X monosomy in two of them. In the remaining 40 women with known 46,XX
spontaneous premature ovarian failure we evaluated the entire coding region of the KIT gene. We
did this using polymerase chain reaction based single-stranded conformational polymorphism
analysis and DNA sequencing. We did not identify a single mutation that would alter the amino acid
sequence of the c-KIT protein in any of 40 patients (upper 95% confidence limit is 7.2%). We found
one silent mutation at codon 798 and two intronic polymorphisms.
Conclusion: Mutations in the coding regions of the KIT gene appear not to be a common cause
of 46,XX spontaneous premature ovarian failure in North American women.
Background
Premature ovarian failure is a condition characterized by
cessation of normal ovarian function before the age of 40.
In most cases a precise mechanism for the ovarian failure
is not identified; however, there is evidence suggesting a
genetic mechanism in at least some cases. [1–4]
Normal ovarian function in reproductive-aged women is
dependent upon the presence of a store of functional pri-
mordial follicles. This store develops from primordial
germ cells, a small population of cells that differentiate
from other cell lineages in very early embryonic life. [5]
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Premature depletion of primordial follicles is a known
mechanism of premature ovarian failure.[6,7]
Studies in mice have demonstrated that c-kit, a transmem-
brane tyrosine kinase receptor, plays a critical role in he-
matopoeisis, melanogenesis, and gametogenesis. The c-kit
receptor kinase and its ligand KL (kit ligand, stem cell fac-
tor) are encoded at the white spotting (W) and steel (Sl)
loci of the mouse, respectively. Various mutations at the
W and the Sl loci have been shown to cause anemia, pig-
mentation defects, and sterility.[8] Point mutations in the
Kit receptor tyrosine kinase in mice can selectively impair
fertility without inducing detectable abnormalities in he-
matopoesis or pigmentation.[9] Studies employing cul-
tured mouse primordial germ cells have demonstrated
that the Steel/Kit interaction is required for germ cell sur-
vival. [10–12]
These observations in mice suggest that mutations in the
human KIT gene (MIM 164920) might be a cause of pre-
mature ovarian failure in women. The human KIT gene is
located on chromosome 4 at map locus 4q12. Mutations
in the human KIT gene have been identified as a cause of
Piebaldism, a rare autosomal dominant disorder of mela-
nogenesis characterized by patchy absence of pigmenta-
tion of the skin and overlying hair.[13,14] Here we test the
hypothesis that specific human KIT mutations might be a
cause of spontaneous premature ovarian failure even in
the absence of detectable disorders of pigmentation or he-
matopoesis.
Methods
Subjects
Our institutional review board approved the study and all
participants signed an informed consent and the proce-
dures of the study were in compliance with the Helsinki
Declaration. The study population comprised 42 women
with premature ovarian failure and 10 normal healthy
control women who had regular menses and proven fer-
tility. Referring physicians made the diagnosis of prema-
ture ovarian failure based on the following criteria:
development of at least 4 months of amenorrhea before
age 40 associated with two serum FSH levels above 40 IU/
L (drawn at least 1 month apart). Women with premature
ovarian failure as a result of surgery, radiation, chemo-
therapy, or known karyotype abnormalities were not in-
cluded in the study. Patients who had not previously had
a karyotype analysis were included pending our analaysis.
There were 34 Caucasian, 6 African American and two
Hispanic women. The median age at the onset of menstru-
al irregularity was 25 years (range 14 to 39, 25th percentile
18.5, 75th percentile 34). Five women had a family history
of premature ovarian failure (two patients had sisters with
premature ovarian failure, one patient's mother had pre-
mature ovarian failure, one had a paternal aunt with pre-
mature ovarian failure, and one patient had a paternal
aunt, a grandmother, and a great-grandmother who were
thought to have the condition). All patients underwent a
history and physical examination and laboratory screen-
ing to confirm the diagnosis of premature ovarian failure.
Cytogenetics
Karyotypes were obtained on all patients. Peripheral
blood specimens were cultured for 72–96 hours using
standard methods and methotrexate-thymidine synchro-
nization.[15] Harvesting and GTW-banding were also per-
formed according to standard cytogenetic protocols.[16]
Fifty metaphases were examined for each patient and
scored for numerical or structural chromosome abnor-
malities. Band resolution was at the 600 band stage or
higher.
Fluorescence in situ hybridization (FISH) was performed
on metaphases from cultured lymphocytes of two patients
with abnormal G-band findings. Chromosome and probe
denaturation, hybridization, detection, and counterstain-
ing were all done according to standard protocols as rec-
ommended by the manufacturer.
DNA extraction and polymerase chain reaction (PCR)
Genomic DNA was extracted from peripheral blood using
standard procedures. Specific primers for PCR amplifica-
tion of the exons were designed based on the human KIT
genomic sequence (Genebank accession number
AC006553, Human chromosome 4) (Table 1). In exon 21
the reverse primer is located in the 3' noncoding region, in
all other cases the primers are located at introns flanking
each exon. The PCR amplification was carried out in a to-
tal volume of 25 µl reaction mixture containing 1.5
mmol/l of MgCL2, 0.2 mmol/l of each dNTP, 50 ng of ge-
nomic DNA, 0.5 µm of each primer, and 1.25 IU of Taq
DNA polymerase per manufacturer's instructions (Invitro-
gen, Carlsbad, CA). The PCR began with an initial dena-
turing at 95°C for 5 minutes. Thereafter the cycling profile
consisted of 35 cycles of denaturing at 95°C for 30 sec-
onds, annealing of the primer pair at the appropriate tem-
perature for 30 seconds (Table 1), and then extension at
72°C for 60 seconds. This was followed by a final stabili-
zation step of 10 minutes at 72°C. After PCR, 5 µl of the
amplified product was examined by 1.5% agarose gel elec-
trophoresis.
Single-stranded conformational polymorphism (SSCP) 
analysis
Analysis of DNA polymorphism was conducted using a
method of "Cold SSCP" as described previously.[17]
Briefly, the PCR products (4 µl) were mixed with SSCP
sample buffer (6 µl, formamide with 0.05% bromophe-
nol blue and xylene cyanol). After denaturing at 95°C for
5 minutes, the DNA samples were placed on ice immedi-BMC Women’s Health 2002, 2 http://www.biomedcentral.com/1472-6874/2/8
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ately and loaded onto precast 20% TBE acrylamide gels
(Tris Base, Boric Acid, EDTA, 4% glycerol, and 20% acry-
lamide, Invitrogen, Carlsbad, CA). Gel elecrophoresis was
run in 1 X TBE buffer at 200 V with the circulator set at 4°C
(using a Penquin Water-cooled Dual-Gel Electrophoresis
system attached to a thermostatically controlled refrigerat-
ed circulator, Amersham & Pharmacia, Uppsala, Sweden).
Gels were stained with ethidium bromide (1 µg/ml) for
20 minutes at room temperature. DNA bands were visual-
ized and photographed under UV light (340 nm).
Direct DNA sequencing
PCR products were either purified using ExoSAP-IT (USB
Co, Cleveland, OH) or subcloned into a TA cloning vector
(Invitrogen, Carlsbad, CA) per the manufacturer's instruc-
tions. DNA sequencing was conducted by PCR (26 cycles
of 96°C, 10 seconds; 50°C 5 seconds; 60°C 4 minutes) us-
ing a dRhodamine terminator cycle sequencing kit (PE
Applied Biosystems, Foster, CA) and 10 µl of purified PCR
product or 1 µg of purified plasmid DNA. The sequencing
samples were separated by 5% Long Ranger gel electro-
phoresis on the ABI Automatic 310 Sequencer (Applied
Biosystems, Foster, CA)
Results
Clinical
None of the 42 women were found to have clinical find-
ings to suggest Turner syndrome. None of the patients had
clinical or laboratory findings to suggest a stem cell defi-
ciency in melanogenesis or hematopoiesis. Two women
were found to have partial monosomy of the X chromo-
some that was felt to be related to the presentation of
spontaneous premature ovarian failure. For this reason
they were excluded from further analysis. These findings
highlight the usefulness of careful cytogenetic screening of
women with spontaneous premature ovarian failure. The
remaining 40 women had a normal 46,XX karyotype anal-
ysis.
One woman of normal stature had a karyotype analysis
showing: 46,X, ?rec(X) dup(Xp) inv(X)(p11.4 q24). ish
rec(X) dup(Xp) inv(X)(p11.4 q24) (KAL++). In all cells
examined there was one normal X chromosome and one
X chromosome that had most of Xp (Xp11.4→Xpter) re-
placing a portion of Xq (Xq24→Xqter). This rearrange-
ment was confirmed with a FISH study. A probe to the
Kallman syndrome region (Oncor Inc., Gaithersburg,
Table 1: Primer sets and conditions for amplification of human KIT exons. Forward and reverse primers flanking each of the 21 exons 
are shown. The size of each exon-coding region, the size of each PCR product generated by each set of primers, and the respective 
annealing temperatures are indicated. Sequences marked by a * are derived from Spritz et al..[28]
Exon No Exon # Size
(bp)
Primers PCR product Size
(bp)
Annealing Tm(°C)
Forward Reverse
1 88(67) 5'GGACCAGAGCTCGGATC3' / 3'AGTCCTCTCTCCGGATG5' 198 62
2 270 5'CTCAGTATTGGAAGAAGTGC3' / 3'TATCTATGGCTCAGTCATCC5' 438 55
3 282 5'GCTTCTATAGATCCTGCC3' / 3'GATCAACGAGAAGAGAAGTC5' * 367 55
4 137 5'TGTACACATTTGAGGAGAAA3' * / 3'CTGACAGACGCACTAGTCG5' * 330 55
5 169 5'TGGAGAAGTTAATTGCTGCT3' * / 3'TGTGCTTTCATTGCAAGAGG5' 435 55
6 190 5'TTGTAATTCCAAGATGAGG3' * / 3'TACTAGGATGAGGACATAGG5' 422 55
7 116 5'TATGTGTGTGCGTGTTTATG3' * / 3'CAAGTTGAGTCCTTGCAGCTG5' * 372 62
8 115 5'CTCCTTGGTTCAGATTCTGC3' / 3'GTGAATTGCAGTCCTTCC5' 321 55
9 194 5'TATGCCACATCCCAAGTG3' / 3'GGTGTGATGCATGTATTACC5' 390 55
10 107 5'ACATAGCTTTGCATCCTGC3' / 3'ATTGTCTCAGTCATTAGAGCAC5' * 280 55
11 127 5'GAGTGCTCTAATGACTGAG3' / 3'CCACTGGAGTTCCTTAAAG5' 266 56
12 105 5'ATGGTCCTTCAATTCCACC3' / 3'TTCTGTCAAATGGGCACTC5' 270 55
13 111 5'GACATCAGTTTGCCAGTTG3' / 3'GCAAGAGAGAACAACAG5' 296 58
14 151 5'GACTAAGTAGTCTGATCC3' / 3'ACCCCATGAACTGCCTGTC5' * 327 55
15 92 5'TAGAGCATGACCCATGAG3' / 3'ACCCACTTGCAACCCTAACT5' * 325 60
16 128 5'GGTATGTCATTGCCACTG3' / 3'GGCTCTAAAATGCTCTGTTCT5' * 296 55
17 123 5'GTGAACATCATTCAAGGCG3' / 3'TTACATTATGAAAGTCACAGG5' * 390 55
18 112 5'CACATTTCAGCAACAGC3' / 3'CCTTCCTTGATCATCTTGT5' * 382 53
19 100 5'CTCAGAGCATCTTCTTGAAG3' / 3'ACATCTGGGTTTCTGTCTC5' 252 58
20 106 5'CCATATGTCCAGTTGCATAG3' / 3'TACCTGAAGCCCAATTTGC5' 257 60
21 2407(129) 5'TGGCCACAAAGTTCTTGG3' / 3'TATCCTGGAGTTGGATGC5' 369 55BMC Women’s Health 2002, 2 http://www.biomedcentral.com/1472-6874/2/8
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MD) at Xp22.3 was hybridized to patient's metaphases
and showed signal on both ends of the abnormal X chro-
mosome (as well as the normal X chromosome) confirm-
ing the G-band impression that both ends of this
chromosome was comprised of Xp. In summary, the pa-
tient had partial trisomy Xp and partial monosomy Xq as
demostrated by G-banding and FISH.
A second woman of normal stature had a karyotype anal-
ysis showing: 46,X, der(X) t (X;13) (q22.3;q14.1). All cells
examined in this patient had extra material on Xq which
was 13q in origin. FISH was performed using whole chro-
mosome probes to the X and 13 (Oncor, Gaithersburg,
MD). The X probe showed signal covering the entire nor-
mal X as well as Xp and the proximal half of Xq on the de-
rivative chromosome. Whole chromosome probe 13
showed signal on the normal 13 as well as on the deriva-
tive X chromosome. These results are consistant with par-
tial monosomy Xq from q22→q terminus and partial
trisomy 13 from q 14.1→q terminus. Given the lack of
symptoms/characteristics associated with trisomy 13
(multiple congenital anomolies with severe cognitive de-
lays) we hypothesize that the derivative X chromosome is
the inactivated X, thus sparing the patient the expected
phenotype.
Screening of the KIT gene
All the exons of the gene (Figure 1A) were successfully am-
plified by PCR in all 10 controls and all 40 patients with
46,XX spontaneous premature ovarian failure. Except for
product 21, which carried only the coding region, each
PCR product contained one complete exon. All PCR prod-
ucts were of the expected size. As shown in Figure 1B, the
size of the 21 PCR products ranged from 198 to 438 bp
and all appeared as a single clear band.
Figure 1
Human KIT organization and PCR amplification of its exons. A. Schematic representation of exon-intron map of
human KIT. It is composed of 21 exons and 20 introns. Vertical bars and horizontal solid lines represent the exons and introns,
respectively. The // indicates that these introns are not in scale. Arabic numbers above each of the vertical bars indicate the
exon number. Modified from Giebel et al.[27].  B. Analysis of PCR products of the human KIT gene. Human genomic DNA
spanning each of the human KIT exons were amplified using specific primer pairs. PCR products for each of the exons were
separated by 1.5% agarose-electrophoresis and stained with ethidium-bromide. The Arabic numbers above each of the PCR
products represent the exon number. DNA size markers (φ X174 RF DNA/HaeIII) are shown at the left of the panel (M).
(B)
(A)
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The PCR products were screened for mutations by SSCP
analysis. We found mobility shifts in the PCR products
from two of the patients and none of the controls. As
shown in Figure 2, patient 4 had a mobility shift in the
products from two exons, 10 and 16; patient 5 had a mo-
bility shift in the product from exon 17. In patient 4 both
the polymorphisms were determined by sequencing to be
within intron regions, and would thus not change the se-
quence of the c-KIT protein. In the polymorphism 71 nu-
cleotides upstream of exon 10, substitution at nucleotide
71 replaced the normal T with an A [IVS9-71T>A]. In the
polymorphism downstream of exon 16 there was a dele-
tion of 5 T nucleotides from within a normal series of 22
consecutive T nucleotides [IVS16 +66_+70delTTTTT] (Fig-
ure 3). In patient 5 sequencing uncovered a mutation at
codon 798; however, the mutation C798T was silent with
no change in amino acid sequence (Isoleucine).
Restriction Fragment Length Polymorphism Analysis
The C798T substitution in exon 17 of patient 5 generates
a new restriction site for SspI (AAT ATT). To determine if
this mutation was homozygous or heterozygous we ana-
lysed restriction fragment length polymorphism (RFLP)
on PCR products. As shown in Figure 4, the mutant PCR
product (390 bp) for exon 17 was digested with SspI to
yield two shorter DNA fragments only (207 and 183 bp).
These data suggest that this mutation is homozygous. We
did not perform RFLP analysis on the mutant PCR prod-
ucts from exons 10 and 16 because no new restriction sites
were generated by the mutations. Other methodologies
such as forced RFLP and sequencing of multiple cloned
products could be applied to determine if these mutations
are homozygous or heterozygous.
Discussion
Primordial germs cells originate from a small number of
progenitor cells that arise in very early development.
Thereafter, complex factors that are not well understood
direct their proliferation, survival, migration to the genital
ridge, differentiation into oocytes, and the subsequent ex-
penditure of oocytes via ovulation or apoptotic
death.[5,7][18] Mutations or deletions in any of the genes
involved in this complex process could theoretically be a
cause of premature ovarian failure on the basis of germ
cell deficiency, either due to a deficient initial endowment
of primordial follicles or an accelerated expenditure of
this endowment.
Evidence that genetic factors play a role in some cases of
premature ovarian failure has been around for a long time
[19,20]. However, the small pedigrees necessarily associ-
ated with this condition make it extremely difficult to con-
duct genetic linkage analysis that can be used to identify
candidate genes.[4] One approach to this dilemma has
been to evaluate candidate genes based on existing knowl-
edge of ovarian physiology, as has been reported in the
case of inhibin.[21] Other candidate genes are those that
when mutated are known to cause germ cell deficiency in
other species, for example the diaphanous gene of dro-
Figure 2
SSCP analysis of KIT PCR products The PCR products
were separated on 20% TBE-acrylamide gel electrophoresis
and stained with ethidium bromide. SSCP analysis of samples
from three normal control women and three patients with
spontaneous premature ovarian failure are shown for exon
10,16, and 17. DNA mobility of PCR products from exons 10
and 16 was altered in one patient (Lane 4). One patient
showed an alternation of DNA mobility in the PCR product
from exon 17 (Lane 5). Also shown is the DNA mobility of
samples from normal women (Lanes 1–3) and from a repre-
sentative patient with no changes in DNA mobility (Lane 6).
Exon 10
12 4 56
Exon 17
Exon 16
Control Patient
3 12 4 56 3
Figure 3
DNA sequence analysis of a KIT intronic region vari-
ant downstream of exon 16 Electropherogram displaying
the sequence of the KIT variant of the intronic sequence
downstream of exon 16 compared to the wild-type
sequence. Arrows indicate a deletion of 5T nucleotides in the
variant as compared to a normal series of 22 consecutive T
nucleotides in the wild-type.
KIT 
Wild type
KIT
Variant
22T
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sophila.[22] Numerous growth factors have been associat-
ed with primordial germ cell behavior during migration in
mice using in vitro studies, but in most cases it is unknown
whether these factors function in vivo.[5] One exception is
the Steel/Kit interaction. Steel and W are genetic loci iden-
tified in strains of mice that exhibit sterility on the basis of
germ cell deficiency. The products of these two loci are
now known to be the tyrosine kinase receptor Kit (W) and
its ligand Steel factor (Steel). It was on this basis that we
set out to examine patients with premature ovarian failure
for mutations in KIT.
The SSCP technique has been used successfully for muta-
tion searching in other genes. [23–26] Using the PCR-
SSCP technique we were able to detect only one polymor-
phism in the entire coding regions of the KIT gene, and
this polymorphism did not change the amino acid se-
quence at codon 798. Therefore, these results suggest that
mutations in the coding regions of the KIT gene are un-
likely to be a common cause of premature ovarian failure.
The upper 95% confidence limit of the proportion 0/40 is
7.2% (no mutations found in 40 women with 46,XX
spontaneous premature ovarian failure). The DNA poly-
morphisms that we identified within intron regions up-
stream of exon 10 and downstream of exon 16 would not
change the amino acid sequence of the c-KIT protein.
However, we cannot exclude the possibility that these
changes in nucleotides that are close to exons might alter
c-KIT transcription, or that mutations in the regulatory re-
gions of the KIT gene might be a cause of spontaneous
premature ovarian failure. Furthermore, it should be not-
ed that SSCP methodology does not detect all mutations
of PCR products. Although in this report using this tech-
nique we were able to detect a single nucleotide mutation
in a PCR product of 390 bp, most laboratories would sug-
gest that SSCP detects approximately 70 to 80% of muta-
tions. Screening a larger group of patients with a more
sensitive technique such as denaturing high-performance
liquid chromatography might detect more mutations.
Conclusions
We were unable to detect any significant mutations in the
entire coding region of the KIT gene in 40 patients with
46,XX spontaneous premature ovarian failure. Therefore,
mutations in the coding regions of the KIT gene do not ap-
pear to be a common cause of 46,XX spontaneous prema-
ture ovarian failure in North American women.
Competing interests
None declared.
Authors' contributions
K.S., Z-B.T, and K.V. participated in the design of the study
and carried out the molecular genetic laboratory studies.
K.S. and Z-B.T. drafted the manuscript. V.H.V. recruited
the patients and helped characterized them clinically.
L.M.N. conceived the study, participated in its design, co-
ordination, analysis and manuscript preparation. All au-
thors read and approved the final manuscript.
Acknowledgements
We thank Jeanne Meck, Ph.D. and the staff of the Georgetown University 
Hospital Cytogenetics Laboratory for classical and molecular cytogenetics 
expertise. We thank Constantine Stratakis, M.D., D.Sc. for reviewing our 
manuscript prior to submission.
References
1. Bondy CA, Nelson LM, Kalantaridou SN: The genetic origins of
ovarian failure. J Womens Health 1998, 7:1225-1229
2. Kalantaridou SN, Davis SR, Nelson LM: Premature ovarian fail-
ure.  Endocrinology and Metabolism Clinics of North America 1998,
27:989-1005
3. van Kasteren YM, Hundscheid RD, Smits AP, Cremers FP, van Zonn-
eveld P, Braat DD: Familial idiopathic premature ovarian fail-
ure: an overrated and underestimated genetic disease? Hum
Reprod 1999, 14:2455-2459
4. Davis CJ, Davison RM, Payne NN, Rodeck CH, Conway GS: Female
sex preponderance for idiopathic familial premature ovarian
failure suggests an X chromosome defect: opinion. Hum Re-
prod 2000, 15:2418-2422
5. Wylie C: Germ cells. Cell 1999, 96:165-174
6. Gosden RG, Faddy MJ: Biological bases of premature ovarian
failure. Reprod Fertil Dev 1998, 10:73-78
7. Tilly JL: Commuting the death sentence: how oocytes strive
to survive. Nat Rev Mol Cell Biol 2001, 2:838-848
8. Besmer P, Manova K, Duttlinger R, Huang EJ, Packer A, Gyssler C, et
al: The kit-ligand (steel factor) and its receptor c-kit/W: plei-
otropic roles in gametogenesis and melanogenesis. Dev Suppl
1993, 125-137
9. Kissel H, Timokhina I, Hardy MP, Rothschild G, Tajima Y, Soares V, et
al: Point mutation in kit receptor tyrosine kinase reveals es-
Figure 4
Restriction fragment length polymorphism analysis
of a KIT variant in exon 17 using Ssp I Undigested DNA
and wild-type DNA digested with Ssp I gives a single band of
390 bp. Homozygosity for the variant yields two fragments of
207 and 183 bp. A heterozygote carrier would have demon-
strated all three of the fragment lengths. Therefore, this
patient is homozygous for this variant.
+-+ -
Wild type Variant
Ssp I
207 bp
183 bp
390 bp
Variant
Wild type
Ssp I
.…….. ……………..aatatt………..……………..
390 bp
207 bp 183 bp
…..…………………aatatc………..……………..BMC Women’s Health 2002, 2 http://www.biomedcentral.com/1472-6874/2/8
Page 7 of 7
(page number not for citation purposes)
Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMedcentral will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Paul Nurse, Director-General, Imperial Cancer Research Fund
Publish with BMC and your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours - you keep the copyright
editorial@biomedcentral.com
Submit your manuscript here:
http://www.biomedcentral.com/manuscript/
BioMedcentral.com
sential roles for kit signaling in spermatogenesis and oogen-
esis without affecting other kit responses.  EMBO J 2000,
19:1312-1326
10. Godin I, Deed R, Cooke J, Zsebo K, Dexter M, Wylie CC: Effects of
the steel gene product on mouse primordial germ cells in
culture. Nature 1991, 352:807-809
11. Dolci S, Williams DE, Ernst MK, Resnick JL, Brannan CI, Lock LF, et
al: Requirement for mast cell growth factor for primordial
germ cell survival in culture. Nature 1991, 352:809-811
12. Matsui Y, Toksoz D, Nishikawa S, Nishikawa S, Williams D, Zsebo K,
et al: Effect of Steel factor and leukaemia inhibitory factor on
murine primordial germ cells in culture. Nature 1991, 353:750-
752
13. Spritz RA, Beighton P: Piebaldism with deafness: molecular ev-
idence for an expanded syndrome.  Am J Med Genet 1998,
75:101-103
14. Richards KA, Fukai K, Oiso N, Paller AS: A novel KIT mutation re-
sults in piebaldism with progressive depigmentation. J Am
Acad Dermatol 2001, 44:288-292
15. Brown MG, Lawce HJ: Peripheral Blood Cytogenetic Methods.
In The AGT Cytogenetics Laboratory Manual.  (Edited by: Barch MJ, Knut-
sen T, Spurbeck JL) Philadelphia: Lippincott-Raven 1997, 99-100
16. Gustashaw KM: Chromosome Stains. In The AGT Cytogenetics Lab-
oratory Manual  (Edited by: Barch MJ, Knutsen T, Spurbeck JL) Philadelphia:
Lippincott-Raven; 1997, 279
17. Hongyo T, Buzard GS, Calvert RJ, Weghorst CM: 'Cold SSCP': a
simple, rapid and non-radioactive method for optimized sin-
gle-strand conformation polymorphism analyses. Nucleic Acids
Res 1993, 21:3637-3642
18. Buehr M: The primordial germ cells of mammals: some cur-
rent perspectives. Exp Cell Res 1997, 232:194-207
19. Coulam CB, Stringfellow S, Hoefnagel D: Evidence for a genetic
factor in the etiology of premature ovarian failure. Fertil Steril
1983, 40:693-695
20. Mattison DR, Evans MI, Schwimmer WB, White BJ, Jensen B, Schul-
man JD: Familial premature ovarian failure. Am J Hum Genet
1984, 36:1341-1348
21. Shelling AN, Burton KA, Chand AL, van Ee CC, France JT, Farquhar
CM, et al: Inhibin: a candidate gene for premature ovarian fail-
ure. Hum Reprod 2000, 15:2644-2649
22. Bione S, Sala C, Manzini C, Arrigo G, Zuffardi O, Banfi S, et al: A hu-
man homologue of the Drosophila melanogaster diaphanous
gene is disrupted in a patient with premature ovarian failure:
evidence for conserved function in oogenesis and implica-
tions for human sterility. Am J Hum Genet 1998, 62:533-541
23. Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, et
al: NPHS2, encoding the glomerular protein podocin, is mu-
tated in autosomal recessive steroid-resistant nephrotic syn-
drome. Nat Genet 2000, 24:349-354
24. Lee MH, Lu K, Hazard S, Yu H, Shulenin S, Hidaka H, et al: Identifi-
cation of a gene, ABCG5, important in the regulation of die-
tary cholesterol absorption. Nat Genet 2001, 27:79-83
25. Semina EV, Ferrell RE, Mintz-Hittner HA, Bitoun P, Alward WL, Reit-
er RS, et al: A novel homeobox gene PITX3 is mutated in fam-
ilies with autosomal- dominant cataracts and ASMD.  Nat
Genet 1998, 19:167-170
26. Azuma N, Hirakiyama A, Inoue T, Asaka A, Yamada M: Mutations of
a human homologue of the Drosophila eyes absent gene
(EYA1) detected in patients with congenital cataracts and
ocular anterior segment anomalies.  Hum Mol Genet 2000,
9:363-366
27. Giebel LB, Strunk KM, Holmes SA, Spritz RA: Organization and
nucleotide sequence of the human KIT (mast/stem cell
growth factor receptor) proto-oncogene.  Oncogene 1992,
7:2207-2217
28. Spritz RA, Giebel LB, Holmes SA: Dominant negative and loss of
function mutations of the c-kit (mast/stem cell growth factor
receptor) proto-oncogene in human piebaldism. Am J Hum
Genet 1992, 50:261-269
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1472-6874/2/8/prepub